According to Towards Healthcare research, the
global animal
genetics market size is valued at USD 6.51 billion in 2024 and is
expected to grow to USD 6.93 billion by 2025. The market is projected to reach
approximately USD 12.11 billion by 2034, expanding at a compound annual growth
rate (CAGR) of 6.4% from 2025 to 2034.

The Complete Study is Now Available for
Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/5446

Wide-range influencing factors on the
animal genetics market expansion, including a rise in demand for animal-derived
protein, like meat, milk, and eggs, breakthroughs in genetic technologies, and
the growing awareness about animal health. Moreover, enhanced focus on superior
breeds and the growth of companion animal ownership are also fueling the
overall market development.

The Animal
Genetics Market: Highlights

•
 North America held a dominating
revenue share by 32% of the market in 2024.

•
 Asia-Pacific is expected to be
the fastest-growing region in the upcoming years.

•
 By animal type, the cattle
segment led the market in 2024.

•
 By animal type, the companion segment
is expected to register rapid expansion during 2025-2034.

•
 By type, the assistive
reproductive technologies segment dominated the animal genetics market in 2024.

•
 By type, the genomic/genetic
segment is expected to grow fastest in the predicted timeframe.

•
 By distribution channel, the
private segment was dominant in the market in 2024 and is expected to show the
fastest growth during 2025-2034.

Market Overview

Primarily, animal genetics is the study of
heredity and diversity in animals, aiming at trait analysis and assessment of
genetic variances which are impacting overall animal characteristics.
Currently, the animal genetics market is propelled by accelerating demand for
animal protein, major technological advances, and the need for sustainable
livestock production. Furthermore, this market contributes to major
developments in the application of CRISPR-Cas9 for gene editing to improve
traits like disease resistance and growth, the progress of genetic testing
services, and the development of tailored breeding techniques. 

Key Metrics and Overview

Metric

Details

Market Size in 2024

USD 6.51 Billion

Projected Market Size in 2034

USD 12.11 Billion

CAGR (2025 – 2034)

6.4%

Leading Region

North America by 32%

Market Segmentation

By Animal Type, By Type, By Distribution Channel, By Region

Top Key Players

Neogen Corporation, EW Group, Envigo, Genus, Norsvin USA, LLC, CRV
Holding B.V., Animal Genetics Inc, Semex, Zoetis, Genus plc, URUS Group LP,
STgenetics

 

You can place an order or ask any
questions, please feel free to contact us at sales@towardshealthcare.com

Widespread Technological Breakthroughs:
Major Potential

In the animal genetics market, several
innovative technological adoptions are boosting the overall market expansion,
including the emergence of genetic selection in the analysis of an animal’s DNA
to estimate its genetic merit for various traits. As well as the application of
novel gene
editing techniques, like CRISPR/Cas9, TALEN, and ZFN, are accurately
altering an animal’s genes to incorporate desired traits or discard undesirable
ones. Moreover, Artificial Insemination (AI) and Embryo Transfer (ET) are
employed to disseminate superior genetics more efficiently. 

Ethical Concerns and Consumer
Preferences: Major Restraint

Globally, the animal genetics market is
facing a few challenges, such as increasing ethical concerns about animal
welfare, biodiversity, and potential ecological impacts. Also, the public’s
seeking and acceptance of genetically modified animals and relevant products
are impacted by these concerns. Moreover, rising demand for higher-quality
products and choices, like lab-grown meat, is creating a major hurdle for this
market development.

The Animal
Genetics Market: Regional Analysis

In 2024, North America dominated the global
market due to the presence of a well-developed livestock industry, coupled with
advanced agricultural practices. Additionally, accelerating consumption of
meat, dairy, and eggs in this region drives the demand for enhanced animal
genetics to boost productivity and efficacy. Besides this, broad adoption of
sophisticated technologies, particularly artificial insemination, embryo
transfer, and genetic screening, is assisting in better animal health,
productivity, and overall performance. 

Whereas, the US is experiencing major
growth, with increased investments in research and development in animal
genetics, with the emergence of artificial insemination, embryo transfer
techniques. Also, the US government is encouraging with their favourable
policies, research funding, and collaborations between academic institutions
and industry players are fostering the novel advancements in the animal
genetics market.

And, another region in North America is
Canada, also facing crucial expansion, as of step towards the development of
sustainable and environmentally friendly farming practices. As well as an
expanded focus on optimizing feed efficiency, minimizing greenhouse gas
emissions from livestock, and encouraging animal health and welfare. 

The Asia Pacific is Predicted to Grow at
a Rapid CAGR During 2025-2034

In the future, the Asia Pacific will expand
rapidly, with growing demand for animal-derived protein, comprising meat,
dairy, and eggs. Besides this, accelerating awareness about the advantages
of advanced genetic technologies to expand animal health, outcomes, and
profitability among farmers and livestock producers. Furthermore, emphasis on
disease management by utilizing genetic testing and breeding programs to detect
and remove genetic diseases in livestock is propelling this region’s animal
genetics market.

In ASAP, India is putting major pressure on
animal-derived food products, as well as the Indian government providing funds
for R&D in animal genetics, which are driving the overall market expansion.
Along with this, “Rashtriya Gokul Mission” in India focuses on
improving the productivity and milk production of bovines through genetic
upgrades. 

For instance,

•  In August
2024, Allozymes, a global innovator in enzyme discovery and engineering, made a
strategic partnership with Adisseo, one of the world’s major animal nutrition
companies, to evolve novel bioprocesses for animal feed ingredient production.

However, in China, significant innovations
in genomic sequencing, gene
editing like CRISPR, and bioinformatics
are revolutionizing breeding programs in the animal genetics market.
These technologies allow more precise and targeted genetic alterations to boost
traits like growth rate, feed efficiency, and disease resistance. 

Get the latest insights on life science
industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership

The Animal
Genetics Market: Segmentation Analysis

By animal type analysis

The cattle segment held the biggest revenue
share of the market in 2024. Around the world, rising cases of genetic
disorders in cattle are primarily contributing to the demand for genetic
testing and breeding programs focused on preventing these concerns. Besides
this, the enormous demand for animal-driven protein food is fueling demand for
highly effective and productive cattle breeds. However, sensor-based
monitoring and AI technologies are accelerating genetic selection processes in
cattle, which enables robust monitoring of livestock health and productivity.

However, the companion segment is estimated
to grow fastest during the forecast period in the animal genetics market. The
segment is driven by a major emphasis on ensuring the health and well-being of
their companion animals among pet owners. This mainly consists of genetic
testing and other advanced services to determine and mitigate possible genetic
conditions. The “humanization” of pets is a crucial trend, resulting
in escalated expenditure on pet care, especially genetic testing and other
advanced services. 

By type analysis

In 2024, the assistive reproductive
technologies segment was dominant in the animal genetics market. Primarily, the
need for robust and sustainable livestock production leads to increased
adoption of ART. Moreover, innovations in artificial insemination, embryo
transfer, in-vitro fertilization, and genome editing are fostering breeding
yield and promoting the broad adoption of these technologies. 

Although the genomic/genetic segment is
anticipated to register a rapid expansion during 2025-2034, to fulfill a vital
pressure for animal-derived protein food products, innovative
and advanced DNA sequencing, bioinformatics, and gene editing
technologies are widely used. Additionally, the segment encompasses tools, such
as CRISPR, enabling targeted changes of animal genes, providing the
possibilities to expand traits like disease resistance, growth rate, and milk
production. Other technologies, mainly artificial insemination and embryo
transfer, are more sophisticated, allowing for the effective dissemination of
desirable genetic traits. 

By distribution channel analysis

During 2024, the private segment dominated
the animal genetics market and will expand fastest in the studied years.
Private distributors are more agile and flexible, enabling them to develop
tailored solutions to satisfy certain customer needs and market
demands. Also, many private companies are heavily investing in R&D to
develop more sophisticated genetic solutions, including DNA sequencing, disease
diagnostics, and tailored breeding programs. Additionally, the
collaboration among public and private sectors, like the joint venture between
Genetics Australia Cooperative and URUS Group LP, is assisting in the market
reach and propelling innovation. 

Top Companies and Their Contributions to
the Animal Genetics Market

Company

Contributions and Offerings

Neogen Corporation

Provides advanced genetic testing and diagnostic solutions to
enhance animal health, breeding, and food safety. Offers genomics tools to
improve livestock productivity and disease resistance.

EW Group

A global leader in poultry genetics, EW Group delivers high-performance
breeding stock and innovative genetic solutions to improve efficiency, animal
welfare, and sustainability in poultry production.

Envigo

Specializes in animal research models and genetics, supporting
pharmaceutical and biotech companies with genetically characterized animals
for research and development.

Genus

A leading animal genetics company focusing on cattle and pigs,
Genus develops superior breeding stock through cutting-edge genomic
technologies to enhance yield, health, and sustainability.

Norsvin USA, LLC

Focuses on swine genetics, providing high-quality breeding stock
and genetic services aimed at improving reproductive performance, growth
rates, and meat quality.

CRV Holding B.V.

Offers dairy cattle genetics globally, enhancing milk production,
fertility, and disease resistance through advanced genomic selection and
breeding programs.

Animal Genetics Inc

Delivers comprehensive genetic testing and analysis services for
livestock, enabling producers to make informed breeding decisions to optimize
traits such as growth and health.

Semex

Provides dairy genetics and reproductive technologies worldwide,
leveraging genomics to improve milk yield, animal health, and longevity in
dairy herds.

Zoetis

Primarily a veterinary pharmaceutical company, Zoetis also offers
genetic testing and diagnostics to support animal health and improve breeding
outcomes across species.

Genus plc

Focuses on global animal genetics, particularly in cattle and
pigs, using genomic tools and breeding expertise to improve production
efficiency, animal health, and sustainability.

 

Elevate your healthcare strategy with
Towards Healthcare. Enhance efficiency and drive better outcomes schedule a
call today: https://www.towardshealthcare.com/schedule-meeting

Browse More Insights of Towards
Healthcare:

The global animal
biotechnology market is experiencing strong growth, rising from $28.17
billion in 2024 to $30.97 billion in 2025, and is expected to reach
approximately $72.6 billion by 2034. This growth reflects a solid CAGR of 9.93%
over the forecast period.

The companion
animal health market is also on a steady upward path, expanding from
$25.28 billion in 2024 to $27.64 billion in 2025, and projected to hit around
$61.74 billion by 2034, growing at a CAGR of 9.34%.

The veterinary
monoclonal antibodies market is gaining rapid traction, growing from
$1.23 billion in 2024 to $1.45 billion in 2025, and expected to soar to about
$6 billion by 2034, driven by a robust CAGR of 17.13%.

The animal
model market continues to expand, increasing from $2.54 billion in 2024
to $2.76 billion in 2025, and forecasted to reach nearly $5.81 billion by 2034,
with a steady CAGR of 8.64%.

The animal
vaccine market is projected to grow significantly, rising from $18.98
billion in 2025 to about $44.77 billion by 2034, supported by a healthy CAGR of
10% throughout the forecast period.

The epigenetic
antibodies market is set for impressive growth, moving from $2.29
billion in 2024 to $2.7 billion in 2025, and expected to reach around $12.01
billion by 2034, expanding at a CAGR of 18.04%.

The direct-to-consumer
genetic testing market is booming, rising from $2.45 billion in 2024 to
$3.05 billion in 2025, with projections showing it could reach approximately
$21.85 billion by 2034, thanks to a rapid CAGR of 24.44%

The genetic
material market is also poised for substantial growth over the next
decade, driven by advances in gene therapies, precision medicine, and biopharma
research.

Meanwhile, the CRISPR
technology market is accelerating, growing from $5.72 billion in 2024
to $6.67 billion in 2025, and forecasted to climb to $26.22 billion by 2034,
reflecting a CAGR of 16.54%.

The molecular
cytogenetics market is on an upward trend, increasing from $2.51
billion in 2024 to $2.78 billion in 2025, and expected to reach $6.9 billion by
2034, with a CAGR of 10.64%.

Animal Genetics Market Companies

•  Neogen Corporation

•  EW Group

•  Envigo

•  Genus

•  Norsvin USA, LLC

•  CRV Holding B.V.

•  Animal Genetics Inc

•  Semex

•  Zoetis

•  Genus plc

•  URUS Group LP

•  STgenetics

Top Companies Latest Updates

Company

Recent Developments

Neogen Corporation (January 2025)

Launched Igenity® BCHF to support the industry in mitigating
bovine congestive heart failure risk

Zoetis (August 2024)

Expanded their capability center in Hyderabad

URUS Group LP (June 2024)

Made a partnership agreement with CVC Capital Partners IX (“CVC”)
to invest in URUS Group

 

What are the Major Drifts in the Animal Genetics Market?

➢ In June 2025, the Federal Government launched the National Strategy
and Action Plan (NSAP) on Animal Genetic Resources (AnGR) management to confirm
effective conservation, application, and development of Nigeria’s livestock
sector.

➢ In March 2025, Telangana is set to accelerate its livestock
breeding and fisheries industries with significant investments of Rs. 21.06 Cr
in new facilities, to enhance the breeding of high-quality dairy cattle around
the state.

➢ In October 2024, Sahel Capital, an investor in the food and
agriculture sector in sub-Saharan Africa approved a $500,000 CAPEX loan from
its Social Enterprise Fund for Agriculture in Africa (SEFAA) facility to
Geneplus, a Kenyan-based company specialising in livestock genetics, providing
dairy farmers with sexed and unsexed cattle semen to support enhancement in
herd productivity and boost milk yields.

➢ In October 2024, Prime Minister Narendra Modi introduced the
Unified Genomic Chip, called ‘Gau Chip’, and indigenous sex-sorted semen
production technology in Maharashtra to support farmers in detecting
high-quality cattle and producing more female calves at affordable expenses.

Animal Genetics Market Segmentation

By Animal Type

•  Cattle

•  Pigs

•  Sheep & Goats

•  Companion Animals

•  Others

By Type

•  Assistive Reproduction Technologies

•  Live Animals

•  Genomic/ Genetic Testing

By Distribution Channel

•  Private

•  Public

By Region

•  North America

•  Asia Pacific

•  Europe

•  Latin America

•  Middle East and Africa (MEA)

Immediate Delivery Available | Buy
This Premium Research @ https://www.towardshealthcare.com/price/5446

You can place an order or ask any
questions, please feel free to contact us at sales@towardshealthcare.com

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical
research services, and advanced analytics, with a strong
emphasis on life science research. Dedicated to
advancing innovation in the life sciences sector, we build strategic partnerships
that generate actionable insights and transformative breakthroughs. As a global
strategy consulting firm, we empower life science leaders to gain a competitive
edge, drive research excellence, and accelerate sustainable growth.

You can place an order or ask any
questions, please feel free to contact us at sales@towardshealthcare.com

Europe Region – +44 778 256 0738

North America Region – +1 8044 4193 44

Web: https://www.towardshealthcare.com

Find us on social platforms: LinkedIn | Twitter | Instagram